All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @mauibigelow on Instagram · 52s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @mauibigelow's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00The straight. Yep. I see it right on the tee. I can get in a tee and it's super skin. I got 12
  2. 0:07and 2 skin and every tee and it's done. That's crazy. Wow. Look at that.
  3. 0:18You can post it. I like to hate the wear jeans. Nice to wear them to do conti. Okay.
  4. 0:26It's the one you do it to show how great the jeans work like for girls with big dailies.
  5. 0:37I haven't been on any of the minute. I'm right. I need to get some of the arm jeans. They like
  6. 0:42faggy and booty part.

Cancer survivor's 200-pound weight loss story, fact-checked

Maui Bigelow

Instagram creator

11.3K viewsView on Instagram

Quick answer

The creator reports a 200-pound weight loss since 2017 while living with Multiple Myeloma, tagging perimenopause hormone therapy as part of her journey. The transcript captured no specific clinical claims about dosing or drug protocols, making this primarily a personal testimony rather than a health instructional video. The intersection of active myeloma treatment and hormone therapy represents a complex clinical picture that requires specialist oversight beyond what any social media account can address.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Cancer survivor's 200-pound weight loss story, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Cancer survivor's 200-pound weight loss story, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Cancer survivor's 200-pound weight loss story, fact-checked" from Maui Bigelow. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator reports a 200-pound weight loss since 2017 while living with Multiple Myeloma, tagging perimenopause hormone therapy as part of her journey.

The reason this review is not generic is the source wording and the canonical claim label "trt let me tell y all something this weight loss journey has be." In this clip, the useful excerpt is: "The straight." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Perimenopause is associated with real metabolic shifts.
People who land here are usually comparing the Testosterone claim with multiplemyeloma, blackwomen, and weightlossjourney.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator reports a 200-pound weight loss since 2017 while living with Multiple Myeloma, tagging perimenopause hormone therapy as part of her journey.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator reports a 200-pound weight loss since 2017 while living with Multiple Myeloma, tagging perimenopause hormone therapy as part of her journey. The transcript captured no specific clinical claims about dosing or drug protocols, making this primarily a personal testimony rather than a health instructional video. The intersection of active myeloma treatment and hormone therapy represents a complex clinical picture that requires specialist oversight beyond what any social media account can address.
  • Testosterone therapy in women is primarily studied for sexual dysfunction, not weight loss. A 2023 Lancet Diabetes and Endocrinology review by Islam et al. found limited and inconsistent evidence for metabolic outcomes in women.
  • Perimenopause is associated with real metabolic shifts. Davis et al. (2012, Climacteric) confirmed declining estrogen changes fat distribution and insulin sensitivity, which hormone therapy can partially address.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone therapy in women is primarily studied for sexual dysfunction, not weight loss. A 2023 Lancet Diabetes and Endocrinology review by Islam et al. found limited and inconsistent evidence for metabolic outcomes in women.
  • Perimenopause is associated with real metabolic shifts. Davis et al. (2012, Climacteric) confirmed declining estrogen changes fat distribution and insulin sensitivity, which hormone therapy can partially address.
  • Multiple Myeloma treatment often involves corticosteroids, which are strongly associated with weight gain, making a 200-pound loss during this period clinically notable rather than typical.
  • Testosterone dosing for women in perimenopause is significantly lower than male hypogonadism protocols. Framing female hormone optimization under a general TRT category risks misleading viewers about appropriate treatment ranges.
  • The FDA has not approved testosterone therapy for weight loss in women. Any hormone regimen pursued for weight management should be supervised by a licensed clinician with full knowledge of any existing cancer diagnoses.
  • A 200-pound weight loss over seven years, if accurate, almost certainly involved multiple sustained lifestyle, medical, and behavioral interventions rather than any single hormone treatment.
  • Anyone with an active cancer diagnosis considering hormone therapy should consult their oncologist first, since myeloma treatment protocols can interact with hormonal therapies in ways that require specialist evaluation.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @mauibigelow actually say?

Honestly, the transcript here is difficult to parse. The recorded audio came through garbled, and what we have reads more like autocaption noise than coherent health claims. What the creator actually communicated clearly is in the caption: she lost 200 pounds since 2017, starting at 376 pounds following a Multiple Myeloma diagnosis, and she's still living with the disease. The hashtags reference hormone therapy, perimenopause, and TRT, which is where the clinical relevance sits.

The transcript itself mentions trying on jeans, talking about fit around the hips and backside, and general body confidence commentary. There are no direct claims about dosing, drug names, or treatment protocols captured in the audio. We're working with what the caption tells us more than what the mic picked up.

Does the science back this up?

A 200-pound weight loss over roughly seven years is medically significant and not scientifically implausible, but it rarely happens through a single intervention. If hormone therapy, including testosterone, played a role, there's real evidence worth considering, though it's not a slam dunk.

Here's what the literature actually shows. A 2019 meta-analysis by Corona et al. in the Journal of Sexual Medicine found that testosterone therapy in women with hypogonadism modestly improved body composition, reducing fat mass while preserving lean mass. The effect sizes were real but not dramatic on their own. Perimenopause is also associated with metabolic shifts, including increased visceral fat accumulation, partly driven by declining estrogen. Research by Davis et al. (2012, Climacteric) confirmed that hormonal changes during perimenopause directly affect fat distribution and insulin sensitivity.

Multiple Myeloma treatment adds another layer. Corticosteroids used in myeloma regimens are notorious for causing weight gain, not loss. A 200-pound reduction while managing myeloma treatment is genuinely remarkable and likely involved multiple interventions working together over years.

What did they get wrong (or right)?

Credit where it's due: the creator is not making extravagant medical claims. She's sharing a personal story, not prescribing a protocol. That restraint matters. She does not claim hormone therapy alone caused her weight loss, and she does not tell viewers to do what she did. That's the right approach.

What's missing, and this is worth naming, is any acknowledgment that her specific medical context, active Multiple Myeloma, makes her situation genuinely unusual. Recommending or implying that perimenopause-era hormone therapy produces dramatic weight loss for the average viewer would be misleading, and she stops short of doing that explicitly.

The TRT category tag on this video is potentially misleading as a framing device. Testosterone therapy for women, when discussed at all, is typically dosed far below male hypogonadism ranges. Lumping female hormone optimization under a TRT label can create confusion about appropriate protocols, expected outcomes, and risk profiles.

What should you actually know?

If you're a woman in perimenopause and you're watching this video wondering whether hormone therapy could help with weight, here's the honest answer: it might help at the margins, particularly with body composition, but it is not a weight loss treatment in the clinical sense. The FDA has not approved testosterone therapy for weight loss in women.

The evidence for testosterone in perimenopausal women primarily covers libido and fatigue, not body weight. A 2023 review by Islam et al. in the Lancet Diabetes and Endocrinology found that while testosterone showed benefits for sexual function in women, evidence for metabolic or weight-related outcomes remained limited and inconsistent.

Anyone seeing this video and living with a serious illness like Multiple Myeloma should talk to their oncologist before starting any hormone therapy. Myeloma and its treatments interact with hormonal pathways in ways that require specialist oversight, not a hashtag-inspired decision.

The bottom line on this video

@mauibigelow is telling her story, not running a clinic. The 200-pound weight loss over seven years while managing cancer is remarkable and should be taken as a personal account, not a replicable protocol. The hormone therapy angle is real but understated in what was actually captured on camera. The science supports a role for hormonal optimization in perimenopause, but the effect on weight specifically is modest, not transformative on its own. Anyone inspired by this video should bring it to a physician, not a supplement brand.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Maui Bigelow · Instagram creator

11.3K views on this video

Let me tell y’all something: this weight-loss journey has been real. I started at 376 pounds back in 2017 when I was diagnosed with Multiple Myeloma, and today… I’m sitting at 175 pounds and yes i sti

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about testosterone therapy in women?

Testosterone therapy in women is primarily studied for sexual dysfunction, not weight loss. A 2023 Lancet Diabetes and Endocrinology review by Islam et al. found limited and inconsistent evidence for metabolic outcomes in women.

What does the video say about perimenopause?

Perimenopause is associated with real metabolic shifts. Davis et al. (2012, Climacteric) confirmed declining estrogen changes fat distribution and insulin sensitivity, which hormone therapy can partially address.

What does the video say about multiple myeloma treatment often involves corticosteroids,?

Multiple Myeloma treatment often involves corticosteroids, which are strongly associated with weight gain, making a 200-pound loss during this period clinically notable rather than typical.

What does the video say about testosterone dosing for women in perimenopause?

Testosterone dosing for women in perimenopause is significantly lower than male hypogonadism protocols. Framing female hormone optimization under a general TRT category risks misleading viewers about appropriate treatment ranges.

What does the video say about the fda has not approved testosterone therapy for weight loss?

The FDA has not approved testosterone therapy for weight loss in women. Any hormone regimen pursued for weight management should be supervised by a licensed clinician with full knowledge of any existing cancer diagnoses.

What does the video say about a 200-pound weight loss over seven years, if accurate, almost?

A 200-pound weight loss over seven years, if accurate, almost certainly involved multiple sustained lifestyle, medical, and behavioral interventions rather than any single hormone treatment.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Maui Bigelow, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.